Aarti Drugs Limited — Board Meeting, 15-05-2026: Outcome of Board Meeting

Aarti Drugs' Board approved consolidated financial results for Q4 & FY26, with Q4 revenue at ₹720.30 Cr and profit at ₹40.54 Cr. They also re-appointed Cost and Internal Auditors and re-constituted the Risk Management Committee.